China Deep Vein Thrombosis Report

September 2022

The China Deep Vein Thrombosis (DVT) report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with performing physicians in Interventional Radiology/Radiology, Vascular Surgery/General Surgery, and Interventional Cardiology/Cardiology departments from level 2 and level 3 hospitals in China.

The report covers:

Deep-vein thrombosis interventional procedures: upper and lower extremity DVT procedures.
Interventional devices: infusion catheters, thrombectomy devices, superior vena cava (SVC) filters, and inferior vena cava (IVC) filters, venous stents, and venous balloons.
Procedure trends: by stages of the disease, extremity, vein clot location, route of access used for the intervention, and type of interventions

“The first is the length of time we have used this brand. If we use it for a long time, we have a good relationship with the brand. We generally seldom use new brands, unless the peers use more or this product can indeed overcome the shortcomings of some existing stents, otherwise we will not use a particularly new stent.”

-Interventional Radiologist, China

~52% of all venous stenting procedures require more than one stent
~58% of all PTA procedures use more than 1 balloon due to the risk of balloon complications
~48% of venous stenting procedures use venous self-expanding stents
~41% of all vena cave filter placement procedures use a temporary IVC filter.

Insights on reimbursement such as the variance of insurance coverage for DVT procedures across provinces and cities based on the type of insurance scheme are delved upon; one of the key findings is that although nearly 70-80% of DVT interventions are covered under public insurance, few patients opt for private insurances to increase coverage – are some of the unique insights covered only in this study.Physician’s brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others affecting brand usage have been covered.
Future trends such as the introduction of new mechanical thrombectomy devices will shorten procedure durations and reduce out-of-pocket expenditure and healthcare expansion will drive volumes in the future.

The coverage of competitor activities includes market events such as emerging companies, product approvals, clinical trials, partnerships, etc. Information on ongoing clinical trials by domestic companies like the SaExten IVCF System in Prevention of PE by ShenZhen KYD Biomedical Technology Co., Ltd and new product developments and acquisitions by key players like Boston Scientific, Cook Medical, Philips Healthcare, and Invamed are covered in the report.

What’s in it for you?

This report will help deep vein thrombosis (DVT) interventional device companies understand the deep vein thrombosis intervention landscape, procedural and technology trends, and the brand perception and competitive intelligence in China.
The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the DVT interventional devices market.

The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
REPORT COST: 5,000 USD
Contact us below for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.

China Deep Vein Thrombosis (DVT) Interventional landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook (2019-2022)

Privacy settings